Back to School: How biopharma can reboot drug development. Access exclusive analysis here

APT raises $22 million

APT (Burlingame, Calif.) raised $22 million in a series A2 round

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE